- JP-listed companies
- KAKEN PHARMACEUTIAL CO., LTD.
KAKEN PHARMACEUTIAL CO., LTD.JP:4521
Market cap
¥179.2B
P/E ratio
22.3x
| Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | |
| Profit (loss) before income taxes | 14,178 | 15,496 | 18,611 | 35,292 | 31,092 | 27,686 | 24,922 | 26,592 | 18,657 | 13,885 | 6,817 | 9,796 |
| Depreciation | 2,607 | 2,538 | 2,400 | 2,242 | 1,937 | 2,124 | 2,153 | 2,312 | 2,318 | 2,481 | 2,546 | 2,596 |
| Impairment losses | - | - | - | - | - | - | - | 287 | - | 2,994 | 1,863 | 19 |
| Amortization of goodwill | - | - | - | - | - | - | - | - | - | 5 | 22 | 157 |
| Increase (decrease) in retirement benefit asset and liability | - | - | - | - | - | - | - | - | - | - | -77 | -141 |
| Interest and dividend income | -152 | -200 | -219 | -232 | -283 | -309 | -351 | -393 | -393 | -397 | -439 | -479 |
| Interest expenses | 68 | 44 | 28 | 27 | 21 | 16 | 17 | 17 | 17 | 17 | 17 | 17 |
| Loss (gain) on investments in investment partnerships | - | - | - | - | - | - | - | - | - | - | 27 | 21 |
| Loss (gain) on sale of investment securities | -31 | - | - | - | -252 | 3 | - | -3 | -115 | -1 | -1 | -13 |
| Loss on retirement of property, plant and equipment | 102 | 24 | 67 | 65 | 122 | 160 | 43 | 61 | 46 | 97 | 48 | 148 |
| Loss (gain) on sale of property, plant and equipment | - | - | 1,179 | - | - | - | - | -4 | -379 | -195 | - | - |
| Decrease (increase) in trade receivables | 858 | 5,811 | -2,841 | -1,664 | 1,637 | -5,084 | 2,975 | 8,539 | 1,251 | 392 | 972 | -4,559 |
| Decrease (increase) in inventories | -605 | -1,690 | -260 | -1,025 | -1,987 | -155 | 2,930 | 1,446 | -2,923 | 241 | -583 | -1,603 |
| Increase (decrease) in trade payables | 35 | -2,653 | -1,418 | -38 | -1,094 | 2,290 | -1,193 | -3,576 | -112 | -2,630 | 280 | 880 |
| Other, net | 389 | -1,198 | 3,093 | -393 | -2,005 | 1,827 | -1,928 | -356 | 915 | 542 | 1,746 | -936 |
| Subtotal | 17,961 | 18,637 | 20,990 | 33,615 | 28,912 | 28,489 | 29,861 | 34,900 | 19,521 | 17,387 | 13,240 | 5,903 |
| Interest and dividends received | 152 | 200 | 219 | 232 | 283 | 309 | 351 | 393 | 393 | 397 | 439 | 479 |
| Interest paid | -65 | -45 | -28 | -27 | -21 | -16 | -17 | -17 | -17 | -17 | -17 | -17 |
| Income taxes refund (paid) | -6,318 | -5,128 | -6,443 | -6,752 | - | - | -9,065 | -7,807 | -5,516 | -4,431 | -4,409 | -3,788 |
| Net cash provided by (used in) operating activities | 11,729 | 13,663 | 14,737 | 27,067 | 15,327 | 21,703 | 21,129 | 27,468 | 14,380 | 13,336 | 9,253 | 2,577 |
| Purchase of property, plant and equipment | -3,845 | -2,071 | -1,954 | -3,124 | -2,166 | -1,689 | -1,908 | -2,159 | -1,973 | -2,986 | -1,987 | -1,861 |
| Proceeds from sale of property, plant and equipment | - | - | 1,941 | - | - | - | - | 7 | 874 | 704 | 12 | 1 |
| Purchase of intangible assets | -69 | -55 | -74 | -93 | -188 | -199 | -220 | -43 | -313 | -271 | -219 | -306 |
| Purchase of investment securities | -1,813 | -3 | -3 | -753 | -1,502 | -1,253 | -1 | - | -20 | - | -200 | - |
| Proceeds from sale of investment securities | 148 | - | - | - | 483 | 1 | - | 5 | 144 | 5 | 5 | 516 |
| Purchase of long-term prepaid expenses | - | - | - | - | - | -110 | -3,661 | -400 | - | - | -218 | -4,182 |
| Other, net | -1,213 | -4 | 565 | -134 | -130 | 6 | 47 | 75 | -357 | -365 | -18 | -22 |
| Net cash provided by (used in) investing activities | -6,792 | -2,135 | 473 | -4,105 | -3,503 | -3,245 | -5,744 | -2,528 | -1,644 | -7,888 | -2,627 | -5,854 |
| Net decrease (increase) in treasury shares | -2,202 | -2,860 | -3,636 | -201 | -3,512 | -3,445 | -3,523 | -4,252 | -2,940 | -2,414 | -1,340 | - |
| Dividends paid | -3,664 | -3,936 | -4,263 | -5,463 | -6,288 | -6,085 | -6,001 | -5,896 | -5,811 | -5,714 | -5,649 | -5,657 |
| Net cash provided by (used in) financing activities | -5,867 | -10,992 | -7,900 | -5,984 | -9,800 | -9,530 | -9,524 | -10,173 | -8,752 | -8,129 | -6,990 | -5,658 |
| Net increase (decrease) in cash and cash equivalents | -930 | 536 | 7,310 | 16,976 | 2,023 | 8,927 | 5,860 | 14,766 | 3,983 | -2,680 | -364 | -8,935 |